Description
This dual-peptide formulation combines CJC-1295 (no DAC) and Ipamorelin, two widely studied compounds in growth hormone signaling research. Together, they are commonly explored for their synergistic interaction with GH release pathways, making them a popular pairing in controlled laboratory environments.
CJC-1295 (no DAC) is a modified growth hormone–releasing hormone (GHRH) analog, while Ipamorelin is a selective growth hormone secretagogue. Their combined use in research settings allows for targeted investigation of pulsatile GH release and endocrine response mechanisms.
Each vial contains 5mg of CJC-1295 (no DAC) and 5mg of Ipamorelin, manufactured to high purity standards to ensure consistency and reliability in analytical applications.
Research Use Only. Not for human or animal consumption.
Reviews
There are no reviews yet.